Related Experiment Video
Updated: Sep 1, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Interaction of Heparin with Proteins: Hydration Effects
Weronika Malicka1, Rainer Haag1, Matthias Ballauff1
1Institut für Chemie und Biochemie, Freie Universität Berlin, 14195 Berlin, Germany.
We studied heparin-lysozyme interactions using potassium glutamate (KGlu) and isothermal titration calorimetry (ITC). KGlu significantly impacts binding free energy, primarily through counterion release and hydration changes, revealing ion-specific Hofmeister effects.
Area of Science:
- Biophysical Chemistry
- Thermodynamics of Biomolecular Interactions
- Polyelectrolyte Science
Background:
- Heparin and lysozyme are key biomolecules with significant biological roles.
- Understanding their interaction is crucial for various biochemical and medical applications.
- The influence of salts on biomolecular complexation is a complex phenomenon involving hydration and ion effects.
Purpose of the Study:
- To thermodynamically investigate the interaction between heparin and lysozyme.
- To elucidate the role of potassium glutamate (KGlu) concentration and temperature on this interaction.
- To compare the effects of KGlu with NaCl, focusing on hydration and ion-specific (Hofmeister) effects.
Main Methods:
- Isothermal Titration Calorimetry (ITC) was employed to measure binding constants (Kb).
- Experiments were conducted across a temperature range (288–310 K) and varying KGlu concentrations (25–175 mM).
- Thermodynamic parameters (ΔGb, Δw, Δcp) were analyzed using model-free approaches like the generalized van't Hoff equation.
Main Results:
- Binding free energy (ΔGb) decreased significantly with increasing KGlu concentration, primarily due to counterion release and entropy increase.
- Temperature dependence of ΔGb was minimal, attributed to hydration changes quantified by a characteristic temperature (T0).
- KGlu demonstrated distinct hydration effects compared to NaCl, with a lower T0, and specific heat (Δcp) became more negative with increasing salt concentration.
Conclusions:
- The study quantifies the significant, albeit small, contribution of hydration changes to the binding free energy of heparin-lysozyme complexation.
- Ion-specific Hofmeister effects are demonstrated and can be quantitatively modeled using T0 and Δcp dependence on salt concentration.
- The findings provide a deeper understanding of salt effects in biomolecular recognition and polyelectrolyte interactions.
More Related Videos
12:27Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
07:54Analysis of AtHIRD11 Intrinsic Disorder and Binding Towards Metal Ions by Capillary Gel Electrophoresis and Affinity Capillary Electrophoresis
Published on: August 22, 2018
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...